StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Cash & Cash Equivalents by Quarter

Cash & Cash Equivalents ($M)

QuarterlyAnnual

Novartis Cash & Cash Equivalents: $8,870M in Q3 2026, down 7.2% from a year earlier.

Latest, Q3 2026
8,870
Period ended Sep 30, 2026
Change on a year earlier
-7.2%
9,556 in Q3 2025
History
40 quarters
Since Q4 2014
Sources
26
Documents cited below

Where the Q3 2026 figure comes from

“|| Cash and cash equivalents | 8 870 | 11 435”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Postgres DB + Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCash & Cash Equivalents ($M)Year on yearSource
Q3 2026Sep 30, 20268,870-7.2%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20267,616+14.4%Novartis 6-K (0001114448-26-000012, filed 2026-07-21) ↗
Q1 2026Mar 31, 20266,877-2.7%Novartis 6-K (0001114448-26-000012, filed 2026-07-21) ↗
Q4 2025Dec 31, 202511,435-0.2%Novartis 20-F (0001114448-26-000004, filed 2026-02-04) ↗
Q3 2025Sep 30, 20259,556-29.8%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 20256,656-15.8%Novartis 6-K (0001370368-25-000012, filed 2025-07-17) ↗
Q1 2025Mar 31, 20257,066-25.4%Novartis 6-K (0001370368-25-000012, filed 2025-07-17) ↗
Q4 2024Dec 31, 202411,459-14.4%Novartis 20-F (0001370368-25-000004, filed 2025-01-31) ↗
Q3 2024Sep 30, 202413,609+9.7%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 20247,903-27.4%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2024Mar 31, 20249,469-21.1%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q4 2023Dec 31, 202313,393+78.2%Novartis 20-F (0001370368-24-000004, filed 2024-01-31) ↗
Q3 2023Sep 30, 202312,405+42.2%Novartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 202310,885+200.3%Novartis 6-K (0001370368-23-000059, filed 2023-07-18) ↗
Q1 2023Mar 31, 202312,000-13.4%Novartis 6-K (0001370368-23-000059, filed 2023-07-18) ↗
Q4 2022Dec 31, 20227,517-39.4%Novartis 20-F (0001370368-23-000006, filed 2023-02-01) ↗

Cite this data

StockData. (2026). Novartis Cash & Cash Equivalents ($M), quarterly Q4 2014–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-bs-cash

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.